Broad Institute of MIT and Harvard Press Releases - EIN Presswire

Published on December 10, 2025 - 23:49 GMT

Findings point to path forward for treatment of rare genetic disease

Friedreich’s ataxia (FA) is a rare but devastating genetic disorder. Those with the condition are often diagnosed between 5 and 15 years of age and live only into their 30s or 40s. There is no widely approved treatment that modifies the disease, and …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on December 9, 2025 - 01:32 GMT

NIH Director Jay Bhattacharya visits Broad to engage with scientists about the impact of federally-funded research

Bhattacharya next met with David Liu, Broad core institute member, the Richard Merkin Professor, and Director of the Merkin Institute for Transformative Technologies in Healthcare at Broad. Liu described his team’s efforts to scale up life-saving gene- …

Distribution channels:

Published on November 25, 2025 - 11:38 GMT

New AI model could speed rare disease diagnosis

Highlights A new AI model called popEVE can predict how likely each variant in a patient’s genome is to cause disease. The team is testing popEVE in clinical settings to see if it can speed accurate diagnoses of rare, single-variant genetic diseases. The …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on November 20, 2025 - 23:26 GMT

Q&A: How an academic-industry alliance is reshaping the way research can lead to new medicines

Contributions to this project were also made by colleagues in the Broad’s technology platforms, including the Genetic Perturbation Platform, the Center for the Development of Therapeutics, and the Proteomics Platform, and by colleagues in the Broad’s …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on November 20, 2025 - 23:26 GMT

FDA approves first cancer drug based on Broad Institute science

The US Food and Drug Administration has approved the first cancer drug based on discoveries from Broad Institute scientists. The drug, sevabertinib, was developed by Bayer Healthcare Pharmaceuticals in close collaboration with the Broad, and is the first …

Distribution channels:

Published on November 20, 2025 - 03:34 GMT

Single prime editing system could potentially treat multiple genetic diseases

A team of researchers at the Broad Institute, led by gene-editing pioneer David Liu, has developed a new genome-editing strategy that could potentially lead to a one-time treatment for multiple unrelated genetic diseases. Gene-editing medicines are often …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on November 19, 2025 - 08:35 GMT

Pandemic prevention system wins MacArthur Foundation’s 100&Change award

The John D. and Catherine T. MacArthur Foundation announced today that it has awarded a $100 million, five-year grant to the Sentinel project — a system for detecting outbreaks in real time and preventing them from growing into potential pandemics. Every …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on November 4, 2025 - 18:12 GMT

Biology of Adversity Project launches at Broad Institute

Most people have experienced distressing events in their lives, such as violence, neglect, or natural disasters. These and other kinds of adverse experiences can have dramatic effects on physical and mental health, yet scientists don’t fully understand how …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on November 2, 2025 - 02:45 GMT

Genetic variant increases risk of heart muscle disease common in individuals of African ancestry

Dilated cardiomyopathy (DCM), a leading cause of heart failure, is twice as common in Black individuals as in white individuals. This excess risk is not fully explained by known risk factors such as high blood pressure or socioeconomic barriers to care. …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on November 2, 2025 - 02:44 GMT

Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize at the Broad Institute for chimeric ...

The 2025 Richard N. Merkin Prize in Biomedical Technology was jointly awarded to Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain in a ceremony and symposium at the Broad Institute on September 30, 2025. The prize, created by the Merkin …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on October 17, 2025 - 08:26 GMT

Broad-Bayer collaboration leads to drug candidate for a hard-to-treat type of lung cancer

An alliance of scientists at the Broad Institute and Bayer Pharmaceuticals have developed a drug candidate, sevabertinib, that could be a new treatment for a group of lung cancer patients who have few options today. In a new study published in Cancer …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on October 16, 2025 - 08:10 GMT

Broad Clinical Labs sets new GUINNESS WORLD RECORDS™ title for fastest DNA sequencing technique

Broad Clinical Labs, in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, today announced official recognition by Guinness World Records for achieving the fastest DNA sequencing technique to date. Leveraging Roche’s new SBX …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on October 9, 2025 - 05:07 GMT

A pioneering effort in patient-partnered cancer research enters a new phase

In 2015, an innovative research initiative called Count Me In launched to give every patient with cancer, no matter where they lived, a way to contribute directly to research and help accelerate advances that could one day lead to new treatments. Since …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on October 1, 2025 - 01:57 GMT

Jason Buenrostro named core institute member at Broad

Broad Institute has appointed Jason Buenrostro as a core institute member. Buenrostro, a leading epigenomics researcher and technology developer, will also join the leadership team of the Epigenomics Program at Broad. Buenrostro is a professor in the …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 23, 2025 - 01:55 GMT

New AI-based diagnostic tool uses epigenomics to accelerate acute leukemia diagnosis

Researchers at Dana-Farber Cancer Institute and the Broad Institute have developed an artificial intelligence-based diagnostic tool that could transform the way acute leukemia is identified and treated. The tool, called MARLIN (Methylation- and AI-guided …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 11, 2025 - 00:45 GMT

#WhyIScience Q&A: A structural biologist adopts a new role catalyzing collaborations

Although Gail Guo’s parents had no formal scientific training, she fondly recalls their curiosity and frequent chats about research discoveries during her childhood in China. They also told Gail about her aunt who’d studied chemistry and moved to the US to …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 9, 2025 - 03:42 GMT

Remembering David Baltimore

Many of you will have heard by now the sad news that David Baltimore passed away on Saturday morning. The New York Times obituary describes David’s roles as one of the greatest scientists and scientific leaders of his generation. His legendary …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 4, 2025 - 00:58 GMT

How massive datasets generated at Broad are powering the latest AI models in biology

In June, Google DeepMind took the wraps off AlphaGenome, its latest machine learning model for biological discovery. While DeepMind's Nobel Prize-winning AlphaFold model focuses on proteins and how they fold, AlphaGenome predicts how genetic variants …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 9, 2025 - 04:02 GMT

Blood-based test provides new diagnostic approach for multiple myeloma

Researchers at Dana-Farber Cancer Institute, Massachusetts General Hospital (MGH), and the Broad Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 7, 2025 - 15:19 GMT

Boston Children’s Hospital, Dana-Farber Cancer Institute, and Broad Clinical Labs launch precision genomics initiative for ...

In a pioneering collaboration aimed at transforming pediatric cancer diagnostics and research, Boston Children’s Hospital (BCH), Dana-Farber Cancer Institute (DFCI), and Broad Clinical Labs have announced the formation of BrightSeq (Boston Research in …

Distribution channels: Healthcare & Pharmaceuticals Industry